Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
22:59
The Pentagon is asking the American defense industry to rapidly increase the production and delivery of weapons.
22:45
CNAS reveals fraud in the healthcare system: Fake consultations for vulnerable patients: "They forgot to ask if the patients are still alive"
22:38
A WHO medical supplies depot in Dnipro, Ukraine, was attacked and destroyed.
22:29
The police in Botoșani discovered a body buried in the yard of a house belonging to a man who went missing in April. His partner has been arrested for qualified murder.
22:05
Elon Musk refuses the use of Starlink by Ukraine for attacks in Russia
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
